Intellia Therapeutics Inc (NASDAQ:NTLA)
| 48.65 Delayed Data As of May 13 |  +6.05 / +14.20%Today’s Change | 38.85 Today|||52-Week Range 202.73 | -58.85% Year-to-Date |
Institutional investors purchased a net $2.2 million shares of NTLA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 81.36% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Mutual fund holders | 56.20% |
| Other institutional | 25.16% |
| Individual stakeholders | 22.58% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 3/31/2022 | ARK INVESTMENT MANAGEMENT LLC Bought 1.1 Million shares of Intellia Therapeutics Inc |
| 3/31/2022 | ALLIANCEBERNSTEIN LP Bought 285.0 Thousand shares of Intellia Therapeutics Inc |
| 3/31/2022 | CITIGROUP GLOBAL MARKETS, INC. (... Bought 273.8 Thousand shares of Intellia Therapeutics Inc |
Top 10 Owners of Intellia Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 12.03% | 8,981,029 | 440,339,852 | +1,064,147 | +13.44% |
| The Vanguard Group, Inc. | 8.31% | 6,208,104 | 304,383,339 | -43,009 | -0.69% |
| BlackRock Fund Advisors | 6.58% | 4,916,381 | 241,050,160 | -40,580 | -0.82% |
| Nikko Asset Management Americas, ... | 3.85% | 2,872,269 | 140,827,349 | +118,366 | +4.30% |
| Fidelity Management & Research Co... | 3.74% | 2,792,391 | 136,910,931 | -1,074,740 | -27.79% |
| T. Rowe Price Associates, Inc. (I... | 2.81% | 2,100,348 | 102,980,062 | -244,190 | -10.42% |
| SSgA Funds Management, Inc. | 2.47% | 1,841,451 | 90,286,343 | +179,721 | +10.82% |
| AllianceBernstein LP | 2.34% | 1,747,681 | 85,688,799 | +285,021 | +19.49% |
| Viking Global Investors LP | 2.12% | 1,579,536 | 77,444,650 | +300,005 | +23.45% |
| Geode Capital Management LLC | 1.64% | 1,226,824 | 60,151,181 | -5,668 | -0.46% |
Top 10 Mutual Funds Holding Intellia Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Innovation ETF | 8.19% | 6,112,757 | 299,708,476 | +89,265 | +1.48% |
| Nikko AM Global Umbrella Fund - A... | 3.18% | 2,377,527 | 116,570,149 | -1,659,603 | -41.11% |
| Vanguard Total Stock Market Index... | 2.61% | 1,945,939 | 95,409,389 | +13,282 | +0.69% |
| ARK Genomic Revolution ETF | 2.40% | 1,794,599 | 87,989,189 | +9,304 | +0.52% |
| Vanguard Small Cap Index Fund | 2.26% | 1,685,083 | 82,619,619 | +2,840 | +0.17% |
| iShares Russell 2000 ETF | 2.05% | 1,530,889 | 75,059,488 | -3,144 | -0.20% |
| Vanguard Small Cap Growth Index F... | 1.36% | 1,017,412 | 49,883,710 | -25,286 | -2.43% |
| SPDR S&P Biotech ETF | 1.31% | 976,556 | 47,880,541 | -315 | -0.03% |
| Vanguard Extended Market Index Fu... | 1.23% | 918,262 | 45,022,386 | +10,927 | +1.20% |
| Fidelity Select Port. - Biotechno... | 1.19% | 885,001 | 43,391,599 | +62,300 | +7.57% |